Engage Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Staccato Alprazolam 1 mg
- First Posted Date
- 2018-05-04
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- Engage Therapeutics, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT03516305
- Locations
- 🇺🇸
Clinilabs Research Unit, Eatontown, New Jersey, United States
Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern
- First Posted Date
- 2018-03-27
- Last Posted Date
- 2021-02-03
- Lead Sponsor
- Engage Therapeutics, Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT03478982
- Locations
- 🇦🇺
The Alfred, Melbourne, Victoria, Australia
🇺🇸Lewis Katz School of Medicine at Template University, Philadelphia, Pennsylvania, United States
🇺🇸Hoag Hospital, Newport Beach, California, United States
© Copyright 2025. All Rights Reserved by MedPath